Dear SOCRA Members,
Change isn’t just inevitable—it’s an opportunity. As SOCRA continues to grow, we’re embracing this moment to strengthen, innovate, and enhance the value we bring to you. That’s why the Board of Directors has made a strategic decision to partner with Parthenon Management Group (PMG)—a trusted Association Management Company with a proven track record of helping professional organizations like ours thrive, evolve, and expand their impact.
This transition isn’t just about change—it’s about unlocking new possibilities for SOCRA and its members. Well-managed organizational shifts create opportunities for:
Greater efficiency – Streamlining operations so we can focus on what truly matters: serving you, our members.
Stronger engagement – Deepening connections between leadership, members, and our community at large.
More innovation – Bringing fresh ideas, forward-thinking strategies, and industry-leading practices.
Long-term sustainability – Ensuring SOCRA remains a strong, future-focused organization for years to come.
Our mission remains the same, but our approach is evolving to meet the needs of today’s clinical research professionals. This partnership positions SOCRA to lead the way, expand professional development opportunities, and create an even more valuable experience for our members.
We’re just getting started—there’s so much more ahead, and we can’t wait to shape this future together!
With the recent NIH supplemental guidance capping all current and future indirect costs at 15%, we find ourselves in a position of significant uncertainty. As clinical research professionals, we are acutely aware of the severe impact this will have on public health, crippling our ability to conduct vital clinical research across the United States.
Indirect costs fund essential functions necessary to support research. These encompass administrative support, maintenance of research facilities, and compliance functions—core components that form the backbone of our research infrastructure. The cap undermines the ability of institutions to sustain comprehensive research environments, thereby jeopardizing scientific innovation and advancements in medical treatments.
SOCRA remains steadfast in its commitment to our members during these challenging times. We recognize your concerns and understand the far-reaching consequences of this policy change. In response, we are actively collaborating with leaders in the industry to advocate for the vital importance of sustained investment in research infrastructure. Our efforts include engaging with stakeholders across the research industry, as well as partnering with other impacted organizations to ensure that the voices of clinical research professionals are heard and acknowledged.
We commend the dedication and resilience of you, our members, and rest assured, SOCRA will continue to stand by you, leveraging our collective strength to ensure that the critical work of advancing public health through clinical research can continue unabated.
Belonging to SOCRA provides you with the information and resources you need to advance your career and enhance your professionalism.
SOCRA
In the fight against cancer, every innovation, discovery, and connection matters. SOCRA’s 2025 Oncology Clinical Trials Conference brings together the...Read More >>
As the spring season begins to bloom, an exciting opportunity awaits oncology clinical trial professionals. The Society of Clinical Research...Read More >>
As 2024 comes to a close, we celebrate another successful year of growth, collaboration, and education within the clinical research...Read More >>
In order to promote quality clinical research, to protect the welfare of research participants, and improve global health, SOCRA's mission is:
To establish educational programming and provide continuing education for clinical research professionals
To establish an internationally recognized certification program for clinical research professionals (CCRP®)
To foster the professional development and peer recognition of clinical research professionals
SOCRA's Vision
That all clinical research fully protects every research participant and is accomplished with excellence, quality, and professionalism.